Wells Fargo’s Acumen Pharmaceuticals ABOS Stock Holding History
Bought
Maintained
Sold
Other funds holding ABOS
Wells Fargo's ABOS Position: Q3 2026 in Review
Wells Fargo reduced its Acumen Pharmaceuticals (ABOS) stake by 62% in Q3 2026, selling an estimated $79.1K and leaving 19,097 shares worth $42.4K. The position accounts for ﹤0.01% of the portfolio, ranked #5598.
Wells Fargo first reported a position in ABOS in Q3 2021 and has held it in 21 quarters since. The position peaked at $133K in Q2 2026. 91 funds tracked by Wall St. Rank hold ABOS as of Q3 2026.
- Wells Fargo held 19,097 shares of Acumen Pharmaceuticals worth $42.4K as of Q3 2026.
- Wells Fargo sold 30,589 Acumen Pharmaceuticals shares in Q3 2026, an estimated $79.1K.
- Acumen Pharmaceuticals made up ﹤0.01% of Wells Fargo's portfolio in Q3 2026, its #5598 holding.
- Wells Fargo first reported a position in Acumen Pharmaceuticals in Q3 2021 and has held it in 21 quarters since.
- Wells Fargo's Acumen Pharmaceuticals position peaked at $133K in Q2 2026.
- 91 funds tracked by Wall St. Rank held Acumen Pharmaceuticals as of Q3 2026.
Based on Wells Fargo's 13F filing for Q3 2026, filed 16 Nov 2026.